Xtx Topco LTD Axogen, Inc. Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$6.63 - $10.69 $32,666 - $52,669	-4,927 Reduced 27.34%	13,093 $105,000
Q4 2023 Feb 13, 2024	SELL	$3.61 - $7.76 $65,730 - $141,294	-18,208 Reduced 50.26%	18,020 $123,000
Q3 2023 Nov 13, 2023	BUY	$4.68 - $9.26 $5,934 - $11,741	1,268 Added 3.63%	36,228 $181,000
Q2 2023 Aug 14, 2023	BUY	$8.5 - $10.38 $297,160 - $362,884	34,960 New	34,960 $319,000

165

36.1M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $770M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.